Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 503692, 13 pages
http://dx.doi.org/10.1155/2015/503692
Research Article

Aberrant Hypermethylation of Aldehyde Dehydrogenase 2 Promoter Upstream Sequence in Rats with Experimental Myocardial Infarction

1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Department of Cardiology, Shandong University, Jinan, Shandong 250012, China
3Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China
4Department of Cardiology, Jining Medical College, Jining, Shandong 272067, China

Received 20 August 2014; Revised 13 November 2014; Accepted 20 November 2014

Academic Editor: Ahmed Abdel-Latif

Copyright © 2015 Peng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Sun, J. C. Ferreira, and D. Mochly-Rosen, “ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance,” Science Translational Medicine, vol. 3, no. 107, Article ID 107ra111, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C.-H. Chen, G. R. Budas, E. N. Churchill, M.-H. Disatnik, T. D. Hurley, and D. Mochly-Rosen, “Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart,” Science, vol. 321, no. 5895, pp. 1493–1495, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. H. Ma, R. Guo, L. Yu, Y. Zhang, and J. Ren, “Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde,” European Heart Journal, vol. 32, no. 8, pp. 1025–1038, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. Y. Zhang, S. A. Babcock, N. Hu, J. R. Maris, H. Wang, and J. Ren, “Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function,” BMC Medicine, vol. 10, article 40, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Liao, A. Sun, Y. Xie et al., “Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction,” Molecular Medicine, vol. 18, no. 5, pp. 785–793, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. Fan, A. Sun, H. Zhao et al., “MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2,” Current Pharmaceutical Design, vol. 19, no. 27, pp. 4865–4873, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Matouk and P. A. Marsden, “Epigenetic regulation of vascular endothelial gene expression,” Circulation Research, vol. 102, no. 8, pp. 873–887, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. T. B. Miranda and P. A. Jones, “DNA methylation: the nuts and bolts of repression,” Journal of Cellular Physiology, vol. 213, no. 2, pp. 384–390, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. S. C. Yan, C. C. Matouk, and P. A. Marsden, “Epigenetics of the vascular endothelium,” Journal of Applied Physiology, vol. 109, no. 3, pp. 916–926, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. A. Fan, K. Ma, X. An et al., “Effects of TET1 knockdown on gene expression and DNA methylation in porcine induced pluripotent stem cells,” Reproduction, vol. 146, no. 6, pp. 569–579, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. C. Bell and G. Felsenfeld, “Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene,” Nature, vol. 405, no. 6785, pp. 482–485, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Movassagh, M.-K. Choy, M. Goddard, M. R. Bennett, T. A. Down, and R. S.-Y. Foo, “Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure,” PLoS ONE, vol. 5, no. 1, Article ID e8564, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. B. Cong, X. Zhu, B. Cao, J. Xiao, Z. Wang, and X. Ni, “Estrogens protect myocardium against ischemia/reperfusion insult by up-regulation of CRH receptor type 2 in female rats,” International Journal of Cardiology, vol. 168, no. 5, pp. 4755–4760, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. Ma, J. Ge, S. Zhang et al., “Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction,” Basic Research in Cardiology, vol. 100, no. 3, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. W. Sheng, H. Wang, X. Ma et al., “LINE-1 methylation status and its association with tetralogy of fallot in infants,” BMC Medical Genomics, vol. 5, article 20, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. Zhang, D. Xu, S. Wang et al., “Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway,” Biomedicine & Pharmacotherapy, vol. 65, no. 8, pp. 590–593, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Zenker, L. Nährlich, H. Sticht, A. Reis, and D. Horn, “Genotype-epigenotype-phenotype correlations in females with frontometaphyseal dysplasia,” American Journal of Medical Genetics, vol. 140, no. 10, pp. 1069–1073, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. P. Trojer and D. Reinberg, “Facultative heterochromatin: is there a distinctive molecular signature?” Molecular Cell, vol. 28, no. 1, pp. 1–13, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. R. Menafra, A. B. Brinkman, F. Matarese et al., “Genome-wide binding of MBD2 reveals strong preference for highly methylated loci,” PLoS ONE, vol. 9, no. 6, Article ID e99603, 2014. View at Google Scholar
  20. H. Zhang, F. Wang, H. R. Kranzler et al., “Identification of methylation quantitative trait loci (mQTLs) influencing promoter DNA methylation of alcohol dependence risk genes,” Human Genetics, vol. 133, no. 9, pp. 1093–1094, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. C. Frazier-Wood, S. Aslibekyan, D. M. Absher et al., “Methylation at CPT1A locus is associated with lipoprotein subfraction profiles,” Journal of Lipid Research, vol. 55, no. 7, pp. 1324–1330, 2014. View at Google Scholar
  22. H. G. Hernández, M. Y. Tse, S. C. Pang, H. Arboleda, and D. A. Forero, “Optimizing methodologies for PCR-based DNA methylation analysis,” BioTechniques, vol. 55, no. 4, pp. 181–197, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. P. Lavigne, P. Espinal, C. Dunyach-Remy, N. Messad, A. Pantel, and A. Sotto, “Mass spectrometry: a revolution in clinical microbiology?” Clinical Chemistry and Laboratory Medicine, vol. 51, no. 2, pp. 257–270, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. K. Balassiano, S. Lima, M. Jenab et al., “Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European prospective investigation into cancer and nutrition (EPIC-EURGAST),” Cancer Letters, vol. 311, no. 1, pp. 85–95, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. D. Xiao, C. Dasgupta, M. Chen et al., “Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats,” Cardiovascular Research, vol. 101, no. 3, pp. 373–382, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. R. Bonasio, S. Tu, and D. Reinberg, “Molecular signals of epigenetic states,” Science, vol. 330, no. 6004, pp. 612–616, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. Taby and J.-P. Issa, “Cancer epigenetics,” CA Cancer Journal for Clinicians, vol. 60, no. 6, pp. 376–392, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. J. Watson, P. Collier, I. Tea et al., “Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype,” Human Molecular Genetics, vol. 23, no. 8, pp. 2176–2188, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. L. P. Breitling, K. Salzmann, D. Rothenbacher, B. Burwinkel, and H. Brenner, “Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease,” European Heart Journal, vol. 33, no. 22, pp. 2841–2848, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. R. P. Talens, J. W. Jukema, S. Trompet et al., “Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction,” International Journal of Epidemiology, vol. 41, no. 1, pp. 106–115, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. P.-Y. Chang, Y.-J. Chen, F.-H. Chang et al., “Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction,” Cardiovascular Research, vol. 99, no. 1, pp. 137–145, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. Kim, T. I. Long, K. Arakawa, R. Wang, M. C. Yu, and P. W. Laird, “DNA methylation as a biomarker for cardiovascular disease risk,” PLoS ONE, vol. 5, no. 3, Article ID e9692, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. G. Fiorito, S. Guarrera, C. Valle et al., “B-vitamins intake, DNA-methylation of one carbon metabolism and homocysteine pathway genes and myocardial infarction risk: the EPICOR study,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 24, no. 5, pp. 483–488, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. C. J. Lagranha, A. Deschamps, A. Aponte, C. Steenbergen, and E. Murphy, “Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females,” Circulation Research, vol. 106, no. 11, pp. 1681–1691, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. Y. Yu, X.-J. Jia, Q.-F. Zong et al., “Remote ischemic postconditioning protects the heart by upregulating ALDH2 expression levels through the PI3K/Akt signaling pathway,” Molecular Medicine Reports, vol. 10, no. 1, pp. 536–542, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. Hirose, S. Kono, S. Tabata et al., “Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: self-Defense Forces Health Study,” Cancer Science, vol. 96, no. 8, pp. 513–518, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. H. A. Lee, S. H. Hong, J. W. Kim, and I. S. Jang, “Possible involvement of DNA methylation in NKCC1 gene expression during postnatal development and in response to ischemia,” Journal of Neurochemistry, vol. 114, no. 2, pp. 520–529, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. D. Subramaniam, R. Thombre, A. Dhar, and S. Anant, “DNA methyltransferases: a novel target for prevention and therapy,” Frontiers in Oncology, vol. 4, article 80, 2014. View at Google Scholar
  39. K. Skowronski, S. Dubey, D. Rodenhiser, and B. L. Coomber, “Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells,” Epigenetics, vol. 5, no. 6, pp. 547–556, 2010. View at Publisher · View at Google Scholar · View at Scopus